back print

Chemical and pharmaceutical

Novo Nordisk A/S (UA): legal advice to Novo Nordisk A/S, a Danish company and worldwide leader in the pharmaceutical industry, concerning the conclusion of a clinical trial agreement in Ukraine.

Astra Zeneca (SK): legal advisory services to Astra Zeneca, one of the world’s leading pharmaceutical companies, on miscellaneous labour law issues.

Krka, d.d., Novo Mesto (BG): legal advisory services to Krka, d.d., Novo Mesto, a Slovenian pharmaceutical company and one of the leading generic pharmaceutical companies in Europe, on various issues of Bulgarian employment law.

I.Q.A. a.s. (USA): legal background of the expansion of the Czech company engaged in clinical research to the American market.

FOURNIER PHARMA and SOLVAY (CZ): tax advisory services in relation to leases rendered to the Czech member of the international pharmaceutical group.

ICON Holdings (UA): comprehensive advisory services to the Irish company engaged in clinical research in connection with renting and furnishing non-residential premises of more than 700 m2 in Kiev.

World leading pharmaceutical company (SK): legal advisory services on acquiring IT services from IBMand founding a subsidiary in Slovakia. 

WALMARK (UA): complex legal advisory services to the Ukrainian company, a multinational pharmaceutical group member, on protecting industrial property.

IG Pharma Holding AG (CZ): comprehensive advisory services to the Swiss company on the sale of its ownership interest in Alpa s.r.o., the Czech producer of medical and cosmetics products.

FOURNIER PHARMA a SOLVAY (CZ): comprehensive advisory services to the international chemical and pharmaceutical group on the restructuring and concentration of its activities in the Czech Republic.

BOIRON (CZ, SK): comprehensive advisory services to the French pharmaceutical group on restructuring and concentrating its operations in the Czech Republic and Slovakia.

WALMARK (UA): comprehensive legal advice to the Ukrainian company, a member of a multinational pharmaceutical company, in connection with the lease of administrative premises in Kiev.

I.Q.A. a.s. (CZ): advisory services to the Czech company engaged in clinical research in connection with the long-term lease of real estate for establishing a research centre.

KRKA (CZ): advisory services to the Slovenian pharmaceutical company concerning the relationship of the company and the executive of the Czech branch.

FOURNIER PHARMA a SOLVAY (CZ): advisory services to the international pharmaceutical group on transfers of employees during restructuring and concentrating its activities in the Czech Republic.

LABORATOIRES URGO (CZ): employment related advisory services to a significant French producer of medical materials related to the terminated employment of the manager.

WALMARK (UA): complex employment related advisory services to the Ukrainian company, a member of the multinational pharmaceutical company.

Leading global supplier of resins (SK): legal assistance to a leading global supplier of resins, gel coats, colorants and additives for composites and cast polymers in connection with its Slovak operations.

INEOS Holdings Limited (SK): legal advisory to the world’s third largest chemical company in corporate matters.

WALMARK (UA): complex legal advisory services to the Ukrainian group, a multinational pharmaceutical group member, on corporate matters including contractual relations with distributors.

French pharmaceutical company (DE, ICC): advisory services to a French pharmaceutical company in arbitration proceedings against a Czech manufacturer of medication, held under ICC rules in Munich (value of dispute: €2 million).

Astra Zeneca (SK): comprehensive legal advisory services to one of the world’s leading pharmaceutical companies regarding outsorcing of IT services and its implementation in Slovakia. 

Astra Zeneca (SK): comprehensive legal advisory services to one of the world’s leading pharmaceutical companies regarding day-to-day business in Slovakia, including real estate issues.  

Novo Nordisk A/S (UA): legal advice to Novo Nordisk A/S, a Danish company and worldwide leader in the pharmaceutical industry, concerning the conclusion of a clinical trial agreement in Ukraine.